Previous 10 | Next 10 |
The US FDA has approved Edwards Lifesciences' ( NYSE: EW ) PASCAL Precision transcatheter valve repair system for transcatheter edge-to-edge repair. The system is used for patients with degenerative mitral regurgitation. It is also engineered with an intuitive cat...
EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION PR Newswire IRVINE, Calif. , Sept. 15, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the compan...
EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL PR Newswire IRVINE, Calif. , Sept. 12, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' br...
Summary Bridgewater Associates’ 13F portfolio value decreased from ~$24.81B to ~$23.60B this quarter. They increased Walmart and CVS Health while dropping Alibaba and JD.com. The top three individual stock positions are Procter & Gamble, Johnson & Johnson, and C...
EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK PR Newswire IRVINE, Calif. , Aug. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transca...
On August 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q2 2022. I curated a list of some high-profile hedge funds and looked into their holdings at the end of June 2022. June was a temporary bottom in the marke...
Momentum's shift into the Health Care sector proved ill-timed last May. Edwards Lifesciences has outperformed lately, but shares are not cheap, and the technical picture is somewhat bearish. An upcoming conference could spark share price volatility. The momentum factor w...
Fisher’s 13F portfolio value decreased from ~$165B to ~$141B in Q2 2022. Johnson & Johnson and Capital One Financial were increased while reducing Eli Lilly and Novo Nordisk this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~15% of t...
Analysis of the top ten pharma and medical device companies shows a 2% advantage for medical device on a total return basis over the last ten years. There are many possible reasons for this difference but patent cliffs and litigation are problems for Pharma. Investors seeking supe...
Avaya Holdings ( AVYA ) -23% on disappointing Q3 prelim results. Roku ( ROKU ) -21% as analysts rush to downgrade following Q2 miss, weak guidance. DexCom ( DXCM ) -13% on Q2 results. Intel ( INTC ) -12% on Q2 results. Cr...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. Edwards has entered into an agreement ...
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877)...
Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has demonstrated progress in its program wi...